Research led by Antonio M. Quispe of Centro de Investigación en Bioingeniería, Universidad de Ingeniería y Tecnología in Peru examined infection rates in Iquitos, Peru at different time points in 2020. Seroprevalence was found to be 70% in the population, which indicates that most people in the area were infected at some point and developed